Anteris Technologies Global Corp.
AVR
Get informed when a big investor buys or sells
+ FollowMarket Cap$658.26M
Close$
$-0.46
106.8% downside
Current Fair Value
106.8% downsideOvervalued by 106.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $658.26 Million |
|---|---|
| Enterprise Value | $404.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.55 |
| Beta | 0.73 |
| Outstanding Shares | 97,340,200 |
Return
| Return on Equity | -41.20% |
|---|---|
| Return on Assets | -38.01% |
| Return on Invested Capital | -40.28% |
Valuation & Multiples
| P/E Ratio | -2.45 |
|---|---|
| PEG | -6.18 |
| Price to Sales | - |
| Price to Book Ratio | 3.39 |
| Enterprise Value to Revenue | 180.28 |
| Enterprise Value to EBIT | -3.95 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$1.50 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.31
Average shareholder expectationRevenue Estimate
$2.75 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Anteris Technologies Global Corp.
174 employees
CEO: Wayne Geoffrey Paterson Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier ...